Luis Rojas‐Espaillat

Laparoendoscopic single-site surgery (LESS) in gynecology: a multi-institutional evaluation

Amanda N. Fader, Luis Rojas‐Espaillat, Okechukwu A. Ibeanu et al. · American Journal of Obstetrics and Gynecology · 2010 · 136 citations

Medicine, Gynecology, Surgery +9

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix

Pedro F. Escobar, Luis Rojas‐Espaillat, S. Tisci et al. · International Journal of Gynecological Cancer · 2006 · 62 citations

Medicine, Gynecology, Pathology +17

CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes.

Amanda N. Fader, Nabila Rasool, S. A. Vaziri et al. · PubMed · 2010 · 44 citations

Medicine, Gynecology, Oncology +17

Phase I dose escalation study of dual PI3K/mTOR inhibition by Sapanisertib and Serabelisib in combination with paclitaxel in patients with advanced solid tumors

David Starks, Luis Rojas‐Espaillat, Casey Williams · Gynecologic Oncology · 2022 · 21 citations · Full text

Pharmacy, Oncology, Pharmacology +17